Back to today’s briefing

Story perspectives

FDA's AI Tool Elsa Faces Backlash Over False Drug Studies

7/25/2025

27 5

Summary

Story summary

The FDA's AI tool, Elsa, is under fire for producing misleading and false studies in drug evaluations. Insiders reveal that Elsa often "hallucinates," sparking fears about the dangers of relying too heavily on AI without sufficient human oversight. These troubling flaws could threaten public health and compromise the integrity of regulatory processes.

1 of 1

Story summary

The FDA's AI tool, Elsa, is under fire for producing misleading and false studies in drug evaluations. Insiders reveal that Elsa often "hallucinates," sparking fears about the dangers of relying too heavily on AI without sufficient human oversight. These troubling flaws could threaten public health and compromise the integrity of regulatory processes.